---------- Forwarded message ----------
From: Yahoo! News Search Results for lung cancer <rssfwd@rssfwd.com>
Date: Fri, Jun 20, 2008 at 4:49 AM
Subject: Epigenomics Successfully Completes Larger Clinical Study in Early Lung Cancer Detection (PrimeNewswire via Yahoo! Finance)
To: mesothelioma77@gmail.com
BERLIN and SEATTLE, June 18, 2008 -- Epigenomics AG , a molecular diagnostics company focusing on the development and commercialization of products for cancer detection based on DNA methylation, today announced that it successfully completed a larger clinical study in its lung cancer program.
Wed, 18 Jun 2008 07:12:56 GMT
___
Source: http://us.rd.yahoo.com/dailynews/rss/search/lung+cancer/SIG=11eqctkpc/*http%3A//biz.yahoo.com/pz/080618/144892.html
--
~
Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc
From: Yahoo! News Search Results for lung cancer <rssfwd@rssfwd.com>
Date: Fri, Jun 20, 2008 at 4:49 AM
Subject: Epigenomics Successfully Completes Larger Clinical Study in Early Lung Cancer Detection (PrimeNewswire via Yahoo! Finance)
To: mesothelioma77@gmail.com
BERLIN and SEATTLE, June 18, 2008 -- Epigenomics AG , a molecular diagnostics company focusing on the development and commercialization of products for cancer detection based on DNA methylation, today announced that it successfully completed a larger clinical study in its lung cancer program.
Wed, 18 Jun 2008 07:12:56 GMT
___
Source: http://us.rd.yahoo.com/dailynews/rss/search/lung+cancer/SIG=11eqctkpc/*http%3A//biz.yahoo.com/pz/080618/144892.html
--
~
Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc